Jose Lutzky Selected Research

MAC combination (MAC protocol)

10/2006

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose Lutzky Research Topics

Disease

29	Melanoma (Melanoma, Malignant) 10/2021 - 10/2002
18	Neoplasms (Cancer) 01/2020 - 10/2002
4	Disease Progression 01/2019 - 12/2009
3	Multiple Myeloma 09/2009 - 06/2005
2	Brain Neoplasms (Brain Tumor) 01/2020 - 05/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2018
2	Uveal melanoma 03/2017 - 06/2014
1	Exanthema (Rash) 01/2019
1	Hypothyroidism 01/2019
1	Pruritus (Itching) 01/2019
1	Herpes Simplex 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2017
1	Nephritis 01/2017
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Thrombotic Thrombocytopenic Purpura 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2015
1	Body Weight (Weight, Body) 08/2010
1	Circulating Neoplastic Cells 04/2010
1	Neoplasm Metastasis (Metastasis) 12/2009

Drug/Important Bio-Agent (IBA)

8	IpilimumabIBA 01/2021 - 02/2010
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 03/2017
5	VaccinesIBA 10/2021 - 10/2002
5	Interleukin-2 (IL2)IBA 01/2018 - 02/2008
4	Immune Checkpoint InhibitorsIBA 01/2021 - 04/2014
4	Monoclonal AntibodiesIBA 10/2019 - 02/2010
4	Imatinib Mesylate (Gleevec)FDA Link 05/2015 - 08/2005
3	AntigensIBA 10/2021 - 10/2002
3	pembrolizumabIBA 01/2021 - 01/2017
3	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 02/2008
2	NivolumabIBA 01/2021 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 12/2020 - 06/2014
2	durvalumabIBA 12/2020 - 10/2019
2	LigandsIBA 10/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 08/2010
2	Pharmaceutical PreparationsIBA 10/2017 - 01/2017
2	AZD 6244IBA 03/2017 - 06/2014
2	Tyrosine Kinase InhibitorsIBA 05/2015 - 08/2005
2	Dacarbazine (DIC)FDA LinkGeneric 06/2014 - 02/2008
2	CTLA-4 AntigenIBA 08/2010 - 02/2010
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2009 - 01/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2009 - 06/2005
2	Bortezomib (Velcade)FDA Link 09/2009 - 06/2005
1	dabrafenibIBA 12/2020
1	trametinibIBA 12/2020
1	encorafenibIBA 01/2020
1	binimetinibIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 10/2019
1	epacadostatIBA 01/2019
1	glembatumumab vedotinIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Codon (Codons)IBA 01/2019
1	Valine (L-Valine)FDA Link 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	talimogene laherparepvecIBA 01/2018
1	VemurafenibIBA 01/2018
1	Radium-223IBA 01/2018
1	thiamine triphosphorate (TTP)IBA 01/2017
1	nilotinib FDA Link 05/2015
1	Adenosine Triphosphate (ATP)IBA 06/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2014
1	poly ICLCIBA 04/2014
1	resiquimodIBA 04/2014
1	Toll-Like Receptor AgonistsIBA 04/2014
1	Axitinib (AG 013736)IBA 12/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2011
1	HLA-A*02:01 antigenIBA 08/2010
1	Protein Subunit VaccinesIBA 08/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2010
1	Biomarkers (Surrogate Marker)IBA 04/2010
1	Dihydrotachysterol (AT 10)IBA 12/2009
1	sargramostim (Leukine)FDA Link 01/2009
1	Thalidomide (Thalomid)FDA Link 01/2009
1	Peptides (Polypeptides)IBA 02/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2008
1	Melphalan (Alkeran)FDA LinkGeneric 10/2006
1	Arsenic Trioxide (Trisenox)FDA Link 10/2006
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2006
1	Diphosphonates (Bisphosphonates)IBA 01/2006
1	apomine (SR 45023A)IBA 01/2006
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 08/2005
1	GangliosidesIBA 10/2002

Therapy/Procedure

19	Therapeutics 10/2021 - 06/2005
7	Immunotherapy 10/2021 - 05/2010
3	Drug Therapy (Chemotherapy) 03/2017 - 12/2009
2	Biological Therapy 04/2010 - 12/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Radiotherapy 01/2018
1	Injections 01/2018
1	Castration 01/2018
1	Retreatment 10/2017
1	Renal Dialysis (Hemodialysis) 01/2015
1	Intralesional Injections 05/2010
1	MAC combination (MAC protocol) 10/2006